Nicolás Garrido Moriana

Mr. Nicolás Garrido Moriana


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in Biomimetics
Verified
Journal Article
Open access
PDF file
NMNicolás Garrido Moriana
Nicolás Garrido Moriana
FGFélix González-Martínez
Félix González-Martínez
SLSusana Losada
Susana Losada
APAdrián Plaza
Adrián Plaza
EOEneida del Olmo
Eneida del Olmo
JMJ Mateo
J Mateo
Artificial intelligence (AI) systems are already being used in various healthcare areas. Similarly, they can offer many advantages in hospital emergency services. The objective of this work is to demonstrate that through the novel use of AI, a trained system can be developed to detect patients at potential risk of infection in a new pandemic more quickly than standardized triage systems. This identification would occur in the emergency department, thus allowing for the early implementation of organizational preventive measures to block the chain of transmission. Materials and Methods: In this study, we propose the use of a machine learning system in emergency department triage during pandemics to detect patients at the highest risk of death and infection using the COVID-19 era as an example, where rapid decision making and comprehensive support have becoming increasingly crucial. All patients who consecutively presented to the emergency department were included, and more than 89 variables were automatically analyzed using the extreme gradient boosting (XGB) algorithm. Results: The XGB system demonstrated the highest balanced accuracy at 91.61%. Additionally, it obtained results more quickly than traditional triage systems. The variables that most influenced mortality prediction were procalcitonin level, age, and oxygen saturation, followed by lactate dehydrogenase (LDH) level, C-reactive protein, the presence of interstitial infiltrates on chest X-ray, and D-dimer. Our system also identified the importance of oxygen therapy in these patients. Conclusions: These results highlight that XGB is a useful and novel tool in triage systems for guiding the care pathway in future pandemics, thus following the example set by the well-known COVID-19 pandemic.

Verified
Journal Article
Open access
PDF file
NMNicolás Garrido Moriana
Nicolás Garrido Moriana
FMFélix González Martinez
Félix González Martinez
ANA MARÍA TORRES ARANDAANA MARÍA TORRES ARANDA
ANA MARÍA TORRES ARANDA
PBPilar Blasco-Segura
Pilar Blasco-Segura
SLSusana Losada
Susana Losada
JMJ Mateo
J Mateo
The COVID-19 pandemic has accelerated advances in molecular biology and virology, enabling the identification of key biomarkers to differentiate between severe and mild cases. Furthermore, the use of artificial intelligence (AI) and machine learning (ML) to analyze large datasets has been crucial for rapidly identifying relevant biomarkers for disease prognosis, including COVID-19. This approach enhances diagnostics in emergency settings, allowing for more accurate and efficient patient management. This study demonstrates how machine learning algorithms in emergency departments can rapidly identify key biomarkers for the vital prognosis in an emerging pandemic using COVID-19 as an example by analyzing clinical, epidemiological, analytical, and radiological data. All consecutively admitted patients were included, and more than 89 variables were processed using the Random Forest (RF) algorithm. The RF model achieved the highest balanced accuracy at 92.61%. The biomarkers most predictive of mortality included procalcitonin (PCT), lactate dehydrogenase (LDH), and C-reactive protein (CRP). Additionally, the system highlighted the significance of interstitial infiltrates in chest X-rays and D-dimer levels. Our results demonstrate that RF is crucial in identifying critical biomarkers in emerging diseases, accelerating data analysis, and optimizing prognosis and personalized treatment, emphasizing the importance of PCT and LDH in high-risk patients.